Avita Total Cash From Financing Activities from 2010 to 2024
| AVH Stock | 3.92 0.02 0.51% |
Total Cash From Financing Activities | First Reported 2000-03-31 | Previous Quarter 631 K | Current Value 849 K | Quarterly Volatility 15.1 M |
Check Avita Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 0.0 or Selling General Administrative of 1.8 M, as well as many indicators such as . Avita financial statements analysis is a perfect complement when working with Avita Therapeutics Valuation or Volatility modules.
Avita | Total Cash From Financing Activities |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avita Stock Analysis
When running Avita Therapeutics' price analysis, check to measure Avita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avita Therapeutics is operating at the current time. Most of Avita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avita Therapeutics' price. Additionally, you may evaluate how the addition of Avita Therapeutics to your portfolios can decrease your overall portfolio volatility.